Across TCGA pan-cancer cohorts, MIR513A2 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR513A2 data layer compared with 8 for mass-spec protein.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR513A2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR513A2 expression acts as an unfavorable survival marker.

DLBC and UCEC are the cancer types where MIR513A2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Median	All	0.053	0.936	<.001	12	view →
UCEC	OS	Median	III,IV	0.061	0.588	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR513A2 tumor-vs-normal RNA expression · all MIR513A2 data types